| INTRODUCTION
Gastro-esophageal reflux is considered a potential risk factor for aspiration and consequently the development of chronic allograft failure in patient's post-lung transplantation (LTx). Early studies assessing esophageal motility abnormalities in these patients therefore mainly focused on factors that might aid the passage of refluxate into the esophagus, such as reduced resting lower esophageal sphincter (LES) pressure, shorter total and abdominal length of the LES, reduced distal esophageal amplitude (DEA), and/or presence of ineffective esophageal motility (IEM), defined in these papers as DEA <30 mm Hg or when >30% simultaneous waves were present in the distal esophagus. [1] [2] [3] [4] [5] These studies however, were inconclusive with some reporting a higher prevalence of IEM and poor acid reflux clearance time in LTx patients with compared to without gastro-esophageal reflux disease (GERD), 2 and correlation between bronchoalveolar lavage fluid pepsin and, LES pressure and DEA, 1 but others showing no difference in motility between those with and without GERD. 3, 6 The one study comparing esophageal motility in LTx patients with and without allograft dysfunction, reported no difference. 7 These studies however, only used conventional manometric parameters and definitions in their analyses, which were further confounded by the use of only pH to record reflux events, thus missing non-acid reflux events captured by impedance.
Using high-resolution esophageal impedance manometry (HRIM)
with the Chicago Classification (CC), version 3.0, and 24-hour pH/impedance, we have recently followed up these initial findings to assess the impact of motor dysfunction as defined by these criteria on both swallowed and reflux bolus clearance and consequently the development of obstructive chronic lung allograft dysfunction (o-CLAD).
8
We showed for the first time that esophagogastric junction outflow obstruction (EGJOO), incomplete bolus transit (IBT) during swallowing, and proximal reflux all increased the risk of o-CLAD. Contrary to expectations, patients with hypo-contractility (eg, absent contractility, IEM and fragmented peristalsis) were no more likely to present with o-CLAD than those with normal motility. However, examination of the LTx patients with normal motility, revealed a higher than anticipated incidence of gastro-esophageal reflux, incomplete transit of boluses swallowed, and peristaltic breaks that fulfilled CC v2.0 criteria for weak peristalsis with breaks that are considered within normal limits using CC v3.0.
Given studies in both patients with GERD 9 and chronic cough 10 using CC version 2.0, have shown that patients with pathological numbers of peristaltic breaks have prolonged reflux clearance times, higher acid exposure times and slower passage of swallowed boluses than those without breaks, we hypothesized that reclassification of our LTx patients using CC v2.0 might alter our findings to show that those with hypo-contractility had increased incidence of o-CLAD than those with normal motility. In other words, we hypothesize that motor abnormalities that are considered to be normal under CC v3.0, may be clinically important in patients who have undergone lung transplant.
Our aim was therefore to compare CC v3.0 with v2.0 to determine how this influenced the prevalence of dysmotility in patients post-LTx, and to assess how this altered the relationship to reflux exposure time, impaired clearance of swallowed boluses as well as refluxate, and association with o-CLAD.
| MATERIALS AND METHODS

| Patients
Consecutive and death. 8 The Mayo Clinic Institutional Review Board approved the study.
| Methods
As described in our recent articles verbatim. • Using CCv2.0 results in hypo-contractility being more likely to be associated with abnormal numbers of reflux events and IBT, risk factors for o-CLAD, and associations not seen using CCv3.0.
• Motor abnormalities, such as peristaltic breaks, deemed within normality using CCv3.0, maybe of importance after lung transplantation.
5-ml saline swallows were given at least 30 seconds apart with the patient supine. Impedance recordings were evaluated for each swallow and bolus clearance assessed using both colorized contour functions and superimposed impedance tracings, as previously described. 
| Statistics
Group differences were evaluated using Student's t tests or MannWhitney U-tests. Associations were assessed using Fisher's exact tests. Cox proportional hazards were completed controlling for length of time between LTx and esophageal testing. Significance was evaluated at the 2-tailed, P < .05 levels.
| RESULTS
Demographics of the patient cohort have been previously reported. As shown in Table 1 Thus, using CC v2.0, 9 (18%) patients were diagnosed with normal motility and 41 (82%) with abnormal motility: 10 (20%) with EGJOO, 13
(26%) with hyper-contractility (Jackhammer (n = 9), distal esophageal spasm (n = 2) and Jackhammer with distal esophageal spasm (n = 2)), 7 (14%) with EGJOOh, and 11 (22%) with hypo-contractility (absent peristalsis (n = 1), frequent failed peristalsis (n = 2), WPLB (n = 1), Hypo-contractility 6 (26) 5 (19) .380
Results expressed as either *median (IQR) or ‡ percentage for categorical variables. CFV, contractile front velocity; DCI, distal contractile integral; DL, distal latency; EGJOO, esophagogastric junction outflow obstruction; HRIM, highresolution esophageal impedance manometry; IRP, integrated relaxation pressure; LES, lower esophageal sphincter; LES-CD, LES to crural diaphragm distance; LTx, lung transplantation; o-CLAD, obstructive chronic lung allograft dysfunction; UES, upper esophageal sphincter. Hyper-contractility 12 (24) 13 (26) EGJOO with hyper-contractility 4 (8) 7 (14) Hypo-contractility 7 (14) 11 (22) CC, Chicago Classification; EGJOO, esophagogastric junction outflow obstruction; LTx, lung transplantation. No significant differences identified between groups.
T A B L E 3 MII and 24-hour MII/pH findings in LTx patients with various esophageal diagnoses based on Chicago Classification v3.0 Results expressed as either *median (IQR), or ‡categorical variables. a P < .05 compared with normal esophageal motility.
BMI, body mass index; EGJOO, esophagogastric junction outflow obstruction without hyper-contractility; EGJOOh, esophagogastric junction outflow obstruction with hyper-contractility; IBT, incomplete bolus transit; LTx, lung transplantation; MII, multichannel intraluminal impedance; o-CLAD, obstructive chronic lung allograft dysfunction.
WPSB (n = 3), and combined WPLB and WPSB (n = 4). These changes in diagnosis were not statistically significant (Table 1) .
| o-CLAD vs without o-CLAD
Irrespective of CC used to diagnose abnormal esophageal motility, patients with o-CLAD were more likely to exhibit EGJOO than patients without o-CLAD (P < .02). There were no other differences in other diagnoses between the two classifications ( Table 2) .
| Abnormal & normal esophageal motility: association with reflux, bolus clearance and o-CLAD
In summary, using CC v3.0, patients with EGJOO (77%) were more likely to develop o-CLAD than those with normal motility (29%, P = .016) ( Table 3) . Patients with EGJOO, however, were less likely to have abnormal numbers of reflux events (10% vs 64%; P = .011) and exhibited reduced reflux bolus exposure time (0.6% vs 1.5%; P = .011) compared with those with normal motility (Table 3) .
Re-classifying patients using CC v2.0, still resulted in patients with EGJOO (80%) been significantly more likely to develop o-CLAD than those with normal motility (22%, P = .019) but the percentage of patients with abnormal numbers of reflux events was no different from those with normal motility (0% vs 33%, NS). Unlike using CC v3.0 however, where patients with hypo-contractility exhibited similar reflux and bolus transit measures to those with normal motility, when using CC v2.0, significantly more patients with hypo-contractility exhibited abnormal reflux (89% vs 33%, P = .025) and increased numbers of total (76 (69-100) vs 39 (27-58); P = .016) and proximal (31 (15-58) vs 13 (6-18); P = .038) reflux events than those with normal motility (Table 4) . Moreover, all patients with hypo-contractility (100%) exhibited incomplete transit of boluses swallowed compared with only 33% of patients with normal motility (P = .002). This was associated with a greater number of swallows being associated with IBT (60 (40-100)) compared with those with normal motility (0 (0-30); P < .001) ( Table 4) .
| DISCUSSION
Our study has shown that in patients following LTx, CC v3.0 classified more patients into EGJOO but fewer patients into the hypocontractility categories than CC v2.0.
Identifying EGJOO has potentially important clinical implications for patient's post-LTx, as it appears to be a significant risk factor for the development of o-CLAD and premature death. with previous studies in chronic cough 10 and GERD, 9 this resulted in the hypo-contractility patient sub-group being significantly more likely to exhibit IBT (100% vs 33%), abnormal reflux (89% vs 33%), and both increased total number and proximal reflux events than those with normal motility. Importantly, these observations suggest that motility patterns/abnormalities identified using CC v2.0 which can be associated with risk factors for the development of o-CLAD (eg IBT, proximal reflux) might be overlooked when using CC v3.0. The fact that the hypo-contractility sub-group was no more likely to develop o-CLAD than those with normal motility, irrespective CC used, is probably because the severity of hypo-contractility and motility patterns seen varied between patients, resulting in differing effects on both transit of boluses swallowed and the proximal extent of reflux, the primary factors driving allograft dysfunction.
In conclusion, CC v3.0 may be more helpful at identifying the motor abnormality EGJOO which is a risk factor for o-CLAD post-LTx.
However, caution should be applied when diagnosing normal motility using CC v3.0, especially if presenting with WPLB and/or WPSB using 
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